Physician profile
Nathan E Pomeroy
NPI 1043338650
$3,559.79
in general payments reported to CMS, 2019-2025
10 companies · $2,273 in 2025
The $2,273 reported for 2025 was more than what 79% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $73.50 · 2021: $119 · 2022: $30.37 · 2023: $621 · 2024: $443 · 2025: $2,273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.81 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,435.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $1,559.99 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $948.37 | 2021-2025 | Jardiance |
| Medtronic, INC. | $541.96 | 2023-2025 | Minimed 780g |
| Dexcom, INC. | $168.66 | 2023-2025 | Dexcom G7 Gss (161), Dexcom G6 Transmitter |
| Sequel Med Tech, LLC | $151.56 | 2025 | Twiist |
| Tandem Diabetes Care, INC. | $79.52 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $41.42 | 2019-2023 | Omnipod |
| Pfizer INC. | $39.78 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $16.20 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Pomeroy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.